Related Experiment Videos
Role of loop diuretics in chronic renal failure
D Russo1, R Minutolo, V E Andreucci
1Department of Nephrology, University of Naples, Italy.
Cardiology
|January 1, 1994
Summary
Torasemide and furosemide have similar natriuretic effects in chronic renal failure. However, torasemide is more potent and longer-acting than furosemide in patients with nephrotic syndrome.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Chronic renal failure (CRF) often requires management of fluid and electrolyte balance.
- Loop diuretics like furosemide and torasemide are commonly used in CRF.
- Nephrotic syndrome complicates CRF, potentially altering diuretic response.
Purpose of the Study:
- To compare the natriuretic effects of furosemide and torasemide.
- To evaluate diuretic efficacy in CRF patients with and without nephrotic syndrome.
Main Methods:
- Comparative study design.
- Assessment of natriuretic activity and duration of action for both drugs.
- Patient groups included CRF without nephrotic syndrome and CRF with nephrotic syndrome.
Main Results:
- Furosemide and torasemide demonstrated comparable natriuretic activity in CRF patients without nephrotic syndrome.
- In CRF patients with nephrotic syndrome, torasemide exhibited superior natriuretic potency compared to furosemide.
- Torasemide also provided a longer duration of natriuretic effect than furosemide in the nephrotic CRF group.
Conclusions:
- Diuretic response to loop diuretics can differ based on the presence of nephrotic syndrome in CRF.
- Torasemide may be a more effective option than furosemide for managing fluid overload in CRF patients with nephrotic syndrome.